Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00643 |
| Species: | Homo sapiens |
| Position : | chr7:84508000-84510000 |
| Year: | 2016 |
| Title: | Utility of next-generation RNA-sequencing in identifying chimeric transcription involving human endogenous retroviruses |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | chronic myeloid leukemia |
| PMID: | 26818267 |
| MONDO: | MONDO:0011998 |
| Tissue: | Bone marrow |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | K562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | chronic myeloid leukemia cell |
| Cell Ontology ID: | CL:0001054 |
| Experiment Type: | Functional perturbation assay |
| High Throughput Method: | RNA-seq, ChIP-seq |
| Low Throughput Method: | RT-RT-qPCR |
| Target gene : | SEMA3A |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|